Adcirca and Lymph follicular hypertrophy - a phase IV clinical study of FDA data
Summary:
Lymph follicular hypertrophy is reported as a side effect among people who take Adcirca (tadalafil), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Opsumit, and have Primary pulmonary hypertension.
The phase IV clinical study analyzes which people have Lymph follicular hypertrophy when taking Adcirca. It is created by eHealthMe based on reports of 54,899 people who have side effects when taking Adcirca from the FDA, and is updated regularly.
What is Adcirca?
Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.
What is Lymph follicular hypertrophy?
Lymph follicular hypertrophy (an increase in the size of the lymph node follicles) is found to be associated with 1,738 drugs and 2,160 conditions by eHealthMe. Check the latest studies of Lymph follicular hypertrophy.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
54,899 people reported to have side effects when taking Adcirca.
Among them, 125 people (0.23%) have Lymph follicular hypertrophy.
Among these 125 people:
How long have people been on Adcirca when they have Lymph follicular hypertrophy? *
What is the gender of people who have Lymph follicular hypertrophy when taking Adcirca? *
What is the age of people who have Lymph follicular hypertrophy when taking Adcirca? *
What are other drugs people take besides Adcirca? *
What are other side effects people have besides Lymph follicular hypertrophy? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Adcirca and have Lymph follicular hypertrophy?
- Check whether Lymph follicular hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Adcirca:
- Adcirca (54,957 reports)
Lymph follicular hypertrophy treatments and more:
- Lymph follicular hypertrophy (47,135 reports)
How severe was Lymph follicular hypertrophy and when was it recovered:
Expand to all the drugs that have ingredients of tadalafil:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Adcirca:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Lymph follicular hypertrophy:
- Lymph follicular hypertrophy (1,738 drugs)
Browse all the conditions that are associated with Lymph follicular hypertrophy:
- Lymph follicular hypertrophy (2,160 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tadalafil (the active ingredients of Adcirca) and Adcirca (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Soft Tissue Infection and drugs of ingredients of estradiol - 4 seconds ago
- Could Ciprofloxacin cause Cardiac Arrest? - 4 seconds ago
- Azelastine Hydrochloride and Sinusitis - Acute for Women aged 30-39 - 6 seconds ago
- Azelastine Hydrochloride and Sinus Infection for Women aged 30-39 - 6 seconds ago
- Azelastine Hydrochloride and Acute Sinusitis for Women aged 30-39 - 6 seconds ago
- Azelastine Hydrochloride and Sinusitis for Women aged 30-39 - 7 seconds ago
- Could Aspirin cause Application Site Erythema? - 9 seconds ago
- Atarax and Dyspnoea for Men aged 60+ - 11 seconds ago
- Atarax and Dyspnea for Men aged 60+ - 11 seconds ago
- Drug interactions of Plendil and Vioxx - 12 seconds ago